Meeting of the National Vaccine Advisory Committee, 2885-2886 [2019-01694]

Download as PDF 2885 Federal Register / Vol. 84, No. 27 / Friday, February 8, 2019 / Notices would enable an assessment of whether any changes identified in individual and contextual risk and protective factors in the intervention group differ from those in the comparison group. The process evaluation will describe in detail each IO’s program, how it was delivered, and factors that may have influenced the success of the program’s implementation. Process evaluation data are necessary for the interpretation of outcome findings and to inform efforts to improve program implementation. Depending on their performance on measures of reliability and validity, the baseline and follow-up questionnaires may be made available to organizations planning to evaluate curricula that are aligned with the SMARTool. Likely Respondents: Respondents will include participants in each of the IOs’ SRA programs (9th or 10th grade youth), their parent(s), program facilitators, representatives of schools participating in the program (e.g., school principals), and school or school district administrative staff. EXHIBIT 1—TOTAL ESTIMATED ANNUALIZED BURDEN HOURS Respondents Number of respondents Form name Number of responses per respondent Average burden per response (in hours) Total burden (hours) Outcome Evaluation Parents .............................................. High school students ........................ School or school district administrative staff. Parental consent .............................. Youth Assent .................................... Baseline survey ................................ Follow-up survey .............................. Classroom roster report ................... 2,356 2,356 2,356 2,120 24 1 1 1 1 1 5/60 5/60 30/60 30/60 120/60 196 196 1,178 1,060 48 48 20 15/60 240 Process Evaluation Program Facilitators .......................... 38 1 25/60 16 1,060 1 10/60 177 Program facilitators, site representatives. Teachers ........................................... Process Evaluation Facilitator Session Log. Process Evaluation Facilitator Survey. Process Evaluation Participant Survey. Process Evaluation Key Informant Interviews. Attendance form ............................... 24 1 60/60 24 48 20 5/60 80 Total burden ............................... ........................................................... ........................ ........................ ........................ 3,135 Program Facilitators .......................... High school students ........................ Terry Clark, Office of the Secretary, Paperwork Reduction Act Reports Clearance Officer. [FR Doc. 2019–01595 Filed 2–7–19; 8:45 am] BILLING CODE 4150–34–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Meeting of the National Vaccine Advisory Committee National Vaccine Program Office, Office of the Assistant Secretary for Health, Office of the Secretary, Department of Health and Human Services. ACTION: Notice. AGENCY: As stipulated by the Federal Advisory Committee Act, the Department of Health and Human Services (HHS) is hereby giving notice that a meeting is scheduled to be held of the National Vaccine Advisory Committee (NVAC). The meeting will be open to the public via teleconference; a public comment session will be held during the meeting. amozie on DSK3GDR082PROD with NOTICES1 SUMMARY: VerDate Sep<11>2014 17:18 Feb 07, 2019 Jkt 247001 The meeting will be held on Monday, March 25, 2019. The confirmed meeting times and agenda will be posted on the NVAC website at http://www.hhs.gov/nvpo/nvac/ meetings/index.html as soon as they become available. ADDRESSES: Instructions regarding attending this meeting will be posted one week prior to the meeting at: http:// www.hhs.gov/nvpo/nvac/meetings/ index.html. Pre-registration is required for members of the public who wish to attend the meeting and who wish to participate in the public comment session. Individuals who wish to attend the meeting and/or participate in the public comment session should register at http://www.hhs.gov/nvpo/nvac/ meetings/index.html. FOR FURTHER INFORMATION CONTACT: Ann Aikin, Acting Designated Federal Officer, at the National Vaccine Program Office, U.S. Department of Health and Human Services, Room 715H, Hubert H. Humphrey Building, 200 Independence Avenue SW, Washington, DC 20201. Phone: (202) 690–5566; email: nvac@ hhs.gov. DATES: PO 00000 Frm 00079 Fmt 4703 Sfmt 4703 Pursuant to Section 2101 of the Public Health Service Act (42 U.S.C. 300aa–1), the Secretary of HHS was mandated to establish the National Vaccine Program to achieve optimal prevention of human infectious diseases through immunization and to achieve optimal prevention against adverse reactions to vaccines. The NVAC was established to provide advice and make recommendations to the Director of the National Vaccine Program on matters related to the Program’s responsibilities. The Assistant Secretary for Health serves as Director of the National Vaccine Program. During the March 2019 NVAC meeting, sessions will consist of presentations on reducing disparities, removing barriers to adult immunization, and reducing financial burdens to vaccination. Please note that agenda items will be related to the charge of the Committee and are subject to change as priorities dictate. Information on the final meeting agenda will be posted prior to the meeting on SUPPLEMENTARY INFORMATION: E:\FR\FM\08FEN1.SGM 08FEN1 2886 Federal Register / Vol. 84, No. 27 / Friday, February 8, 2019 / Notices the NVAC website: http://www.hhs.gov/ nvpo/nvac/index.html. Members of the public will have the opportunity to provide comments at the NVAC meeting during the public comment periods designated on the agenda. Public comments made during the meeting will be limited to three minutes per person to ensure time is allotted for all those wishing to speak. Individuals are also welcome to submit their written comments. Written comments should not exceed three pages in length. Individuals submitting written comments should email their comments to the National Vaccine Program Office (nvac@hhs.gov) at least five business days prior to the meeting. Ann Aikin, Acting Designated Federal Officer. [FR Doc. 2019–01694 Filed 2–7–19; 8:45 am] BILLING CODE 4150–44–P DEPARTMENT OF HEALTH AND HUMAN SERVICES [Document Identifier: HHS–OS–0990– College Sexual Assault Policy] Agency Information Collection Request: 30-Day Public Comment Request Office of the Secretary, HHS. Notice. AGENCY: ACTION: In compliance with the requirement of the Paperwork Reduction Act of 1995, the Office of the Secretary (OS), Department of Health and Human Services, is publishing the following summary of a proposed collection for public comment. DATES: Comments on the ICR must be received on or before March 11, 2019. SUMMARY: grantee and partner experiences with the initiative; barriers and facilitators to project implementation; sustainability of grantee efforts; and anecdotal or other evidence of reductions in campus sexual violence. Interviews conducted with individuals representing the grantee organizations and campus partners, and will occur once per respondent in the spring of 2019. The CDC estimates that 23 million women have experienced completed or attempted rape in their lifetimes. (National Intimate Partner and Sexual Violence Survey, https://www.cdc.gov/ mmwr/preview/mmwrhtml/ss630 8a1.htm). A September 2015 Association of American Universities (AAU) survey of 150,000 students across 27 colleges and universities indicated that 23% of female undergraduate students reported experiencing sexual assault since enrolling in college (AAU Campus Climate Survey on Sexual Assault and Sexual Misconduct, https:// www.aau.edu/sites/default/files/%40% 20Files/Climate%20Survey/Executive% 20Summary%2012-14-15.pdf). The College Sexual Assault Policy, and Prevention Initiative of the Department of Health and Human Services, Office of Women’s Health, has three main goals: (1) Disseminate sexual assault policy and prevention information to organizations in a position to influence and implement policies and practices at post-secondary schools; (2) provide technical assistance to post-secondary schools to establish policies and practices that prevent sexual assault; and (3) assess the success of policy establishment and sustained prevention strategies enacted by partnering organizations and postsecondary schools. Submit your comments to OIRA_submission@omb.eop.gov or via facsimile to (202) 395–5806. FOR FURTHER INFORMATION CONTACT: Sherrette Funn, Sherrette.Funn@hhs.gov or (202) 795–7714. When submitting comments or requesting information, please include the document identifier 0990–New–30D and project title for reference. ADDRESSES: Interested persons are invited to send comments regarding this burden estimate or any other aspect of this collection of information, including any of the following subjects: (1) The necessity and utility of the proposed information collection for the proper performance of the agency’s functions; (2) the accuracy of the estimated burden; (3) ways to enhance the quality, utility, and clarity of the information to be collected; and (4) the use of automated collection techniques or other forms of information technology to minimize the information collection burden. Title of the Collection: Cross-Site Evaluation on the Women’s Health College Sexual Assault Policy and Prevention Initiative. Type of Collection: New. OMB No.: 0990–College Sexual Assault Policy; Office of Women’s Health within OS. Abstract: The Office of Women’s Health is seeking an approval by OMB on a new information collection, CrossSite Evaluation on the Women’s Health College Sexual Assault. The purpose of this data collection is to gather qualitative data across the nine grantee organizations and partners via interviews to gain a full understanding of grantee and partner perceived success over the course of the three-year project; SUPPLEMENTARY INFORMATION: ESTIMATED ANNUALIZED BURDEN TABLE amozie on DSK3GDR082PROD with NOTICES1 Number of responses per respondent Number of respondents Type of respondent Average burden per response (in hours) Total burden hours Grantee organization representative ............................................................... Partner campus representative ....................................................................... 9 36 1 1 1 1 9 36 Total .......................................................................................................... ........................ ........................ ........................ 45 Terry Clark, Office of the Secretary, Paperwork Reduction Act Reports Clearance Officer. DEPARTMENT OF HEALTH AND HUMAN SERVICES [FR Doc. 2019–01596 Filed 2–7–19; 8:45 am] Announcement of Meeting of the Secretary’s Advisory Committee on National Health Promotion and Disease Prevention Objectives for 2030 BILLING CODE 4150–33–P Office of Disease Prevention and Health Promotion, Office of the AGENCY: VerDate Sep<11>2014 17:18 Feb 07, 2019 Jkt 247001 PO 00000 Frm 00080 Fmt 4703 Sfmt 4703 Assistant Secretary for Health, Office of the Secretary, Department of Health and Human Services. ACTION: Notice. The U.S. Department of Health and Human Services (HHS) announces the next two meetings of the Secretary’s Advisory Committee on National Health Promotion and Disease SUMMARY: E:\FR\FM\08FEN1.SGM 08FEN1

Agencies

[Federal Register Volume 84, Number 27 (Friday, February 8, 2019)]
[Notices]
[Pages 2885-2886]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-01694]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Meeting of the National Vaccine Advisory Committee

AGENCY: National Vaccine Program Office, Office of the Assistant 
Secretary for Health, Office of the Secretary, Department of Health and 
Human Services.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: As stipulated by the Federal Advisory Committee Act, the 
Department of Health and Human Services (HHS) is hereby giving notice 
that a meeting is scheduled to be held of the National Vaccine Advisory 
Committee (NVAC). The meeting will be open to the public via 
teleconference; a public comment session will be held during the 
meeting.

DATES: The meeting will be held on Monday, March 25, 2019. The 
confirmed meeting times and agenda will be posted on the NVAC website 
at http://www.hhs.gov/nvpo/nvac/meetings/index.html as soon as they 
become available.

ADDRESSES: Instructions regarding attending this meeting will be posted 
one week prior to the meeting at: http://www.hhs.gov/nvpo/nvac/meetings/index.html. Pre-registration is required for members of the 
public who wish to attend the meeting and who wish to participate in 
the public comment session. Individuals who wish to attend the meeting 
and/or participate in the public comment session should register at 
http://www.hhs.gov/nvpo/nvac/meetings/index.html.

FOR FURTHER INFORMATION CONTACT: Ann Aikin, Acting Designated Federal 
Officer, at the National Vaccine Program Office, U.S. Department of 
Health and Human Services, Room 715H, Hubert H. Humphrey Building, 200 
Independence Avenue SW, Washington, DC 20201. Phone: (202) 690-5566; 
email: nvac@hhs.gov.

SUPPLEMENTARY INFORMATION: Pursuant to Section 2101 of the Public 
Health Service Act (42 U.S.C. 300aa-1), the Secretary of HHS was 
mandated to establish the National Vaccine Program to achieve optimal 
prevention of human infectious diseases through immunization and to 
achieve optimal prevention against adverse reactions to vaccines. The 
NVAC was established to provide advice and make recommendations to the 
Director of the National Vaccine Program on matters related to the 
Program's responsibilities. The Assistant Secretary for Health serves 
as Director of the National Vaccine Program.
    During the March 2019 NVAC meeting, sessions will consist of 
presentations on reducing disparities, removing barriers to adult 
immunization, and reducing financial burdens to vaccination. Please 
note that agenda items will be related to the charge of the Committee 
and are subject to change as priorities dictate. Information on the 
final meeting agenda will be posted prior to the meeting on

[[Page 2886]]

the NVAC website: http://www.hhs.gov/nvpo/nvac/index.html.
    Members of the public will have the opportunity to provide comments 
at the NVAC meeting during the public comment periods designated on the 
agenda. Public comments made during the meeting will be limited to 
three minutes per person to ensure time is allotted for all those 
wishing to speak. Individuals are also welcome to submit their written 
comments. Written comments should not exceed three pages in length. 
Individuals submitting written comments should email their comments to 
the National Vaccine Program Office (nvac@hhs.gov) at least five 
business days prior to the meeting.

Ann Aikin,
Acting Designated Federal Officer.
[FR Doc. 2019-01694 Filed 2-7-19; 8:45 am]
 BILLING CODE 4150-44-P